1-12 of 12
Sally A. Hunsucker
Close
Sort by
Journal Articles

Development of a mRNA Lipid Nanoparticle (mRNA-LNP) Cancer Vaccine to Prevent Leukemia Relapse after Stem Cell Transplant

Anson Snow, Lin Lin, Sally A. Hunsucker, Ying Wang, Rihe Liu, Paul M. Armistead
Journal: Blood
Blood (2022) 140 (Supplement 1): 7382–7383.
https://doi.org/10.1182/blood-2022-160218
Published: 2022
Journal Articles

Identification of Leukemia Associated Minor Histocompatibility Antigens through Computational Prediction and Targeted Mass Spectrometry

Jefferson L. Lansford, BS, Udara Dharmasiri, PhD, Shengjie Chai, BS, Sally A. Hunsucker, PhD, Dante S. Bortone, PhD, James E. Keating, BS, Ian M. Schlup, Gary L. Glish, PhD, Edward J. Collins, PhD, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD PhD, Benjamin G. Vincent, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 207.
https://doi.org/10.1182/blood.V130.Suppl_1.207.207
Published: 2017
Journal Articles

Rapid Assessment of Minimal Residual Acute Myeloid Leukemia from Peripheral Blood Using a Microfluidic Chip

Joshua M. Jackson, MS, James Taylor, BS, Malgorzata Witek, PhD, Sally A. Hunsucker, PhD, Jennifer Paulsen Waugh, MD, Yuri D. Fedoriw, MD, Thomas C. Shea, MD, Steven A. Soper, PhD, Paul M. Armistead, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1389.
https://doi.org/10.1182/blood.V126.23.1389.1389
Published: 2015
Journal Articles

UNC-GRK4-1: An Allele Specific Cancer Testis Antigen Identified Through Genomic Screening

Udara Dharamsiri, PhD, Sally A. Hunsucker, PhD, Benjamin G. Vincent, MD, Michael Wu, PhD, Edward J. Collins, PhD, Shoudan Liang, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3246.
https://doi.org/10.1182/blood.V122.21.3246.3246
Published: 2013
Journal Articles

RNA-Seq Expression Profiling of AML Stem Cells Reveals Differential Expression of Lineage Differentiation Markers and Novel Splice Variants.

Benjamin G Vincent, MD, Darshan Singh, MS, Michael Wu, PhD, Sally A. Hunsucker, PhD, Gheath Alatrash, DO, PhD, Kathryn Ruisaard, MS, Pariya Sukhumalchandra, BS, Karen Clise-Dwyer, PhD, Jonathan S Serody, MD, Jan F Prins, PhD, Jeffrey J. Molldrem, M.D., Paul M. Armistead, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2502.
https://doi.org/10.1182/blood.V120.21.2502.2502
Published: 2012
Journal Articles

Mer Receptor Tyrosine Kinase Is A Potential Therapeutic Target in Acute Myeloid Leukemia

Alisa B. Lee-Sherick, MD, Kelly Menachof, Kristen M. Eisenman, MD, Amy McGranahan, Colleen McGary, Sally A. Hunsucker, PhD, Jennifer Schlegel, Paul M Armistead, MD, PhD, Xiayuan Liang, MD, Dmitri Kireev, William Janzen, Jing Liu, Michael Stashko, Jacqueline Norris-Drouin, H. Shelton Earp, III, Xiaodong Wang, Stephen Frye, Deborah DeRyckere, PhD, Douglas K. Graham, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1317.
https://doi.org/10.1182/blood.V120.21.1317.1317
Published: 2012
Journal Articles

Identification of Leukemia Associated Antigens From ANKRD17 and CDK4 Using Mass Spectrometry Based Screening,

Colleen McGary, BS, Atim A. Enyenihi, PhD, Sally A. Hunsucker, PhD, Patricia A. Ropp, PhD, Tania Rodriguez-Cruz, BS, Gregory Lizee, PhD, Gheath Alatrash, DO, PhD, Gary L. Glish, PhD, Paul M. Armistead, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4020.
https://doi.org/10.1182/blood.V118.21.4020.4020
Published: 2011
Journal Articles

A Novel HLA-A2 Restricted Peptide Derived From Cathepsin G Is An Effective Immunotherapeutic Target for Myeloid Leukemia

Mao Zhang, MPH, Pariya Sukhumalchandra, BS, Atim A. Enyenihi, PhD, Lisa S St. John, PhD, Sally A. Hunsucker, PhD, Kathryn Ruisaard, MS, Zein Al Atrache, Patricia A Ropp, PhD, Tania Rodriguez-Cruz, BS, Elizabeth Mittendorf, MD, Gregory Lizee, PhD, Karen Clise-Dwyer, PhD, Sijie Lu, PhD, Gary L. Glish, PhD, Jeffrey J. Molldrem, MD, Paul M Armistead, MD, PhD, Gheath Alatrash, D.O., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 2986.
https://doi.org/10.1182/blood.V118.21.2986.2986
Published: 2011
Journal Articles

Inhibition of Interleukin-6 Signaling with CNTO 328 Sensitizes Plasma Cell Dyscrasias to the Effects of Melphalan in Association with Suppression of Signaling through Protein Kinase B/Akt.

Sally A. Hunsucker, Ph.D., Valeria Magarotto, M.D., Jairo A. Matthews, B.A., Michael Wang, M.D., Veerabhadran Baladandayuthapani, Ph.D., Peter M. Voorhees, M.D., Hong Xie, M.D., Mark Cornfeld, M.D., M.P.H., Jeffrey A. Nemeth, M.D., Ph.D., Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 1836.
https://doi.org/10.1182/blood.V114.22.1836.1836
Published: 2009
Journal Articles

Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors

Deborah J. Kuhn, Sally A. Hunsucker, Qing Chen, Peter M. Voorhees, Marian Orlowski, Robert Z. Orlowski
Journal: Blood
Blood (2009) 113 (19): 4667–4676.
https://doi.org/10.1182/blood-2008-07-171637
Published: 2009
Includes: Supplemental data
Journal Articles

Enhancing Activity of Bortezomib Against Multiple Myeloma (MM) through Inhibition of Interleukin (IL)-6 Signaling: A Role for Repression of Myeloid Cell Leukemia (Mcl)-1.

Peter M. Voorhees, George W. Small, Deborah J. Kuhn, Qing Chen, Sally A. Hunsucker, Robert Corringham, Carlos A. Garay, Mohamed H. Zaki, Jeffrey Nemeth, Robert Z. Orlowski
Journal: Blood
Blood (2006) 108 (11): 3414.
https://doi.org/10.1182/blood.V108.11.3414.3414
Published: 2006
Journal Articles

CNTO328 Abrogates Glucocorticoid (GC) Resistance Conferred by Interleukin (IL)-6 and the Bone Marrow Microenvironment in Multiple Myeloma (MM).

Peter M. Voorhees, George W. Small, Deborah J. Kuhn, Qing Chen, Sally A. Hunsucker, Robert Corringham, Carlos A. Garay, Mohamed H. Zaki, Jeffrey Nemeth, Robert Z. Orlowski
Journal: Blood
Blood (2006) 108 (11): 3473.
https://doi.org/10.1182/blood.V108.11.3473.3473
Published: 2006